Protein-kinase activity is directly related to fibrosis [100], and several molecules have been studied to inhibit them. Ruboxistaurin, a protein-kinase C inhibitor, showed promising initial results in the fields of retinopathy and peripheral neuropathy [101, 102]. Here, WEE1 is linked to peripheral neuropathy.